QQ客服 官方微博 反馈留言

	Rapamycin enhances the sensitivity of ER‑positive breast cancer cells to tamoxifen by upregulating p73 expression.
	Zhu Lei; Li Xiao-Xia; Shi Liang; Wu Jing; Qian Jia-Yi; Xia Tian-Song; Zhou Wen-Bin; Sun Xi; Zhou Xu-Jie; Wei Ji-Fu
刊名	Oncology reports
	2018
ISSN号	1791-2431
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5460643
专题	湖南大学
作者单位	Jiangsu Breast Disease Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China. Department of Critical Care Medicine, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China. Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
推荐引用方式 GB/T 7714	Zhu Lei,Li Xiao-Xia,Shi Liang,et al. Rapamycin enhances the sensitivity of ER‑positive breast cancer cells to tamoxifen by upregulating p73 expression.[J]. Oncology reports,2018.
APA	Zhu Lei.,Li Xiao-Xia.,Shi Liang.,Wu Jing.,Qian Jia-Yi.,...&Ding Qiang.(2018).Rapamycin enhances the sensitivity of ER‑positive breast cancer cells to tamoxifen by upregulating p73 expression..Oncology reports.
MLA	Zhu Lei,et al."Rapamycin enhances the sensitivity of ER‑positive breast cancer cells to tamoxifen by upregulating p73 expression.".Oncology reports (2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。